反応式
[F:1][C:2]1([F:20])[CH2:7][CH2:6][NH:5][CH:4]([CH2:8][N:9]2[C:17](=O)C3C(=CC=CC=3)C2=O)[CH2:3]1.[CH3:21][C:22]1[CH:23]=[CH:24][C:25]([C:31]2[N:36]=[CH:35][CH:34]=[CH:33][N:32]=2)=[C:26]([CH:30]=1)[C:27]([OH:29])=O.ClC1[N:43]=[CH:42][C:41]([C:44]([F:47])([F:46])[F:45])=[CH:40][N:39]=1>>[F:20][C:2]1([F:1])[CH2:7][CH2:6][N:5]([C:27]([C:26]2[CH:30]=[C:22]([CH3:21])[CH:23]=[CH:24][C:25]=2[C:31]2[N:36]=[CH:35][CH:34]=[CH:33][N:32]=2)=[O:29])[C@H:4]([CH2:8][NH:9][C:17]2[N:43]=[CH:42][C:41]([C:44]([F:47])([F:46])[F:45])=[CH:40][N:39]=2)[CH2:3]1参加物
4
反応物 3
生成物 1
実験手順
The title compound was prepared following the same general protocol as described for Example A210 using 2-((4,4-difluoropiperidin-2-yl)methyl)isoindoline-1,3-dione and 5-methyl-2-(pyrimidin-2-yl)benzoic acid and Example A45 using 2-chloro-5-(trifluoromethyl)pyrimidine. ESI-MS (m/z): 493 (M+H).
出典と根拠
- ORDレコード
- ord-911f1feac7ab449b9ad60381a434343f
- 出典データセット
- uspto-grants-2016_09
- 特許番号
- US09440982B2
関連ノート
読み込み中…